BR112013028221A2 - composição para tratamento de distúrbios autoimunes e métodos da mesma - Google Patents
composição para tratamento de distúrbios autoimunes e métodos da mesmaInfo
- Publication number
- BR112013028221A2 BR112013028221A2 BR112013028221A BR112013028221A BR112013028221A2 BR 112013028221 A2 BR112013028221 A2 BR 112013028221A2 BR 112013028221 A BR112013028221 A BR 112013028221A BR 112013028221 A BR112013028221 A BR 112013028221A BR 112013028221 A2 BR112013028221 A2 BR 112013028221A2
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- treatment
- methods
- autoimmune disorders
- relates
- Prior art date
Links
- 208000023275 Autoimmune disease Diseases 0.000 title abstract 2
- TVNGRDSDHVARNR-SYQAKRSCSA-N (2R,3R,4S,5S,6R)-2-[(2R)-4-[(1R,2S,4S,6R,7S,8R,9S,12S,13S,15R,16R,18S)-6,15-dihydroxy-7,9,13-trimethyl-16-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxy-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosan-6-yl]-2-methylbutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound C[C@H](CC[C@@]1(O)O[C@H]2C[C@H]3[C@@H]4CC[C@H]5C[C@@H](O[C@@H]6O[C@H](CO[C@@H]7OC[C@@H](O)[C@H](O)[C@H]7O)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2[C@@H]1C)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O TVNGRDSDHVARNR-SYQAKRSCSA-N 0.000 abstract 1
- OVMFOVNOXASTPA-MCIQUCDDSA-N 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-6-[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]chromen-4-one Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C([C@H]2[C@@H]([C@@H](O)[C@H](O)CO2)O)=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O OVMFOVNOXASTPA-MCIQUCDDSA-N 0.000 abstract 1
- DRLZZQRQMWQRLZ-UHFFFAOYSA-N 6-C-Arabinosyl-8-C-glucosyl apigenin Natural products OCC1OC(C(O)C1O)c2c(O)c(C3OC(CO)C(O)C(O)C3O)c4OC(=CC(=O)c4c2O)c5ccc(O)cc5 DRLZZQRQMWQRLZ-UHFFFAOYSA-N 0.000 abstract 1
- 206010018364 Glomerulonephritis Diseases 0.000 abstract 1
- 208000024869 Goodpasture syndrome Diseases 0.000 abstract 1
- 206010021245 Idiopathic thrombocytopenic purpura Diseases 0.000 abstract 1
- OVMFOVNOXASTPA-UHFFFAOYSA-N Neoisoschaftoside Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C(C2C(C(O)C(O)CO2)O)=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O OVMFOVNOXASTPA-UHFFFAOYSA-N 0.000 abstract 1
- 244000250129 Trigonella foenum graecum Species 0.000 abstract 1
- 235000001484 Trigonella foenum graecum Nutrition 0.000 abstract 1
- 201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 abstract 1
- 235000001019 trigonella foenum-graecum Nutrition 0.000 abstract 1
- TVNGRDSDHVARNR-UHFFFAOYSA-N trigoneoside Ia Natural products O1C(CO)C(O)C(O)C(O)C1OCC(C)CCC(C(C1C2(C)CCC3C4(C)CC5O)C)(O)OC1CC2C3CCC4CC5OC(C(C(O)C1O)O)OC1COC1OCC(O)C(O)C1O TVNGRDSDHVARNR-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
resumo patente de invenção: "composição para tratamento de distúrbios autoimunes e métodos da mesma". a presente invenção refere-se a uma composição compreendendo trigoneosídeo ib e vicenina-1 para tratamento e gerenciamento de doença de goodpasture, glomerulonefrite, artrite reumatoide, lupus sistêmico eritematoso, e trombocitopenia idiopática púrpura. a presente invenção também refere-se a um método para obtenção da dita composição a partir de trigonella foenum-graecum.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1367MU2011 | 2011-05-02 | ||
| IN1367/MUM/2011 | 2011-05-02 | ||
| PCT/IB2011/052592 WO2012150486A1 (en) | 2011-05-02 | 2011-06-15 | A composition for treating autoimmune disorders and methods thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112013028221A2 true BR112013028221A2 (pt) | 2017-01-17 |
| BR112013028221B1 BR112013028221B1 (pt) | 2022-01-04 |
Family
ID=47090391
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013028221-5A BR112013028221B1 (pt) | 2011-05-02 | 2011-06-15 | Composição para tratamento de distúrbios autoimunes, seu uso e seu método de preparação |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8513203B2 (pt) |
| EP (1) | EP2704710B1 (pt) |
| JP (1) | JP5760145B2 (pt) |
| KR (1) | KR101628853B1 (pt) |
| CN (1) | CN103517709B (pt) |
| AU (1) | AU2011367351B2 (pt) |
| BR (1) | BR112013028221B1 (pt) |
| CA (1) | CA2833324C (pt) |
| ES (1) | ES2664187T3 (pt) |
| TW (1) | TWI449527B (pt) |
| WO (1) | WO2012150486A1 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104926896A (zh) * | 2015-06-19 | 2015-09-23 | 武汉光谷人福生物医药有限公司 | 从广金钱草中提取分离Vicenin-1的方法和系统 |
| AU2016322956B2 (en) * | 2015-09-19 | 2019-09-12 | Indus Biotech Private Limited | Composition and methods thereof |
| USD870125S1 (en) | 2018-07-31 | 2019-12-17 | Samsung Electronics Co., Ltd. | Display screen or portion thereof with transitional graphical user interface |
| CN112299997B (zh) * | 2020-11-20 | 2022-12-20 | 河南大学 | 一种从Nigella sativa种籽中分离提取链状酯类化合物的方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI955691A (fi) * | 1994-11-28 | 1996-05-29 | Suntory Ltd | Lipoproteiini(a):ta alentava aine, kolesterolia alentava aine ja näitä aineita sisältävät lääkkeet |
| US5707631A (en) | 1996-04-30 | 1998-01-13 | Advanced Plant Pharmaceuticals Incorporated | Therapeutic herbal composition |
| US6080401A (en) | 1998-11-19 | 2000-06-27 | Reddy; Malireddy S. | Herbal and pharmaceutical drugs enhanced with probiotics |
| NL1021288C2 (nl) * | 2002-08-16 | 2004-02-17 | Exenta B V | Kruidenextract, alsmede de toepassing van een dergelijk kruidenextract. |
| AU2003289658A1 (en) * | 2003-12-19 | 2005-07-05 | Ming Qi Oncology Chinese Medicines, Inc | Pharmaceuticals of chinese traditional medicine of treating lung cancer and preparation method thereof |
| US20050226948A1 (en) * | 2004-03-02 | 2005-10-13 | Lee Steve S | Methods for enhancing the transport of glucose into muscle |
| JP5372358B2 (ja) * | 2007-01-20 | 2013-12-18 | 美智士 谷 | 生体活性治療物質 |
| CA2682138A1 (en) * | 2007-04-13 | 2008-10-23 | V-Biotek Holding Aps | Extract of trigonella foenum-graecum |
| WO2010134100A2 (en) * | 2009-05-22 | 2010-11-25 | Bio-Ved Pharmaceuticals, Pvt. Ltd. | A method for extraction of fractions containing pharmacologically active ingredients with less cytotoxicity from one or more plants |
-
2011
- 2011-06-14 US US13/160,347 patent/US8513203B2/en active Active
- 2011-06-15 CA CA2833324A patent/CA2833324C/en active Active
- 2011-06-15 KR KR1020137031474A patent/KR101628853B1/ko active IP Right Grant
- 2011-06-15 ES ES11864742.9T patent/ES2664187T3/es active Active
- 2011-06-15 EP EP11864742.9A patent/EP2704710B1/en active Active
- 2011-06-15 CN CN201180070564.7A patent/CN103517709B/zh active Active
- 2011-06-15 BR BR112013028221-5A patent/BR112013028221B1/pt active IP Right Grant
- 2011-06-15 JP JP2014508880A patent/JP5760145B2/ja active Active
- 2011-06-15 AU AU2011367351A patent/AU2011367351B2/en active Active
- 2011-06-15 WO PCT/IB2011/052592 patent/WO2012150486A1/en active Application Filing
- 2011-08-19 TW TW100129711A patent/TWI449527B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2704710B1 (en) | 2017-12-27 |
| JP5760145B2 (ja) | 2015-08-05 |
| TW201300112A (zh) | 2013-01-01 |
| CN103517709B (zh) | 2017-05-03 |
| EP2704710A1 (en) | 2014-03-12 |
| ES2664187T3 (es) | 2018-04-18 |
| US20120282332A1 (en) | 2012-11-08 |
| CN103517709A (zh) | 2014-01-15 |
| JP2014518856A (ja) | 2014-08-07 |
| RU2013153238A (ru) | 2015-06-10 |
| CA2833324A1 (en) | 2012-11-08 |
| KR101628853B1 (ko) | 2016-06-09 |
| KR20140003644A (ko) | 2014-01-09 |
| EP2704710A4 (en) | 2014-11-26 |
| AU2011367351B2 (en) | 2015-11-19 |
| AU2011367351A1 (en) | 2013-11-07 |
| CA2833324C (en) | 2015-06-30 |
| US8513203B2 (en) | 2013-08-20 |
| WO2012150486A1 (en) | 2012-11-08 |
| TWI449527B (zh) | 2014-08-21 |
| BR112013028221B1 (pt) | 2022-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL274469A (en) | Compositions, uses and methods for the treatment of metabolic disorders and diseases | |
| HK1258231A1 (zh) | 治療阿爾茨海默氏症、亨廷頓氏症、孤獨症和其他障礙的方法 | |
| BR112014014276A2 (pt) | composto, composição farmacêutica, método para inibir uma cinase receptora, e, métodos para tratar condições, doenças e/ou distúrbios, e dor | |
| CO6612271A2 (es) | Anticuerpos anti-cd40 | |
| MY180626A (en) | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof | |
| BR112014005389A8 (pt) | Sal cloridrato de 4- (3-metanossulfonil-fenil) -1- propil-piperidina em uma forma cristalina, composição farmacêutica compreendendo o mesmo e usos do dito sal | |
| EA201071245A1 (ru) | Новые терапевтические подходы для лечения болезни альцгеймера и связанных нарушений посредством модулирования реакции клеток на стресс | |
| EA201691121A1 (ru) | Гидроксиамидные соединения пиримидина в качестве ингибиторов деацетилаз белков и способы их применения | |
| BR112013022927A2 (pt) | composição, métodos para substituir ou suplementar ou modificar uma microbiota do cólon de um sujeito, e para tratar um sujeito, e, uso de uma composição | |
| EA201270767A1 (ru) | Терапия на основе лигандов хемосенсорных рецепторов | |
| UY33863A (es) | Metodos y medicamentos para el tratamiento de la enfermedad de alzheimer | |
| EP2734500A4 (en) | SELECTIVE HISTONDEACETYLASE-6 INHIBITORS FOR THE TREATMENT OF BONE DISORDERS | |
| BR112012017051A2 (pt) | método para diminuir a imunogenicidade | |
| EA201391332A1 (ru) | Лиганды опиоидных рецепторов и способы их применения и получения | |
| CL2008003316A1 (es) | Forma cristalina vi de la agomelatina; procedimientos de preparacion; composicion farmaceutica, util para el tratamiento de estres, ansiedad, depresion mayor, ataques de panico, enfermedad de parkinson, epilepsia, enfermedad de alzheimer. | |
| MY177742A (en) | Crystalline forms of 5-chloro-n2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl-n4[2-(propane-2-sulfonyl)-phenyl]-pyrimidine-2,4-diamine | |
| EA201101686A1 (ru) | Новые композиции для лечения шмт и связанных с ней расстройств | |
| EA201590520A1 (ru) | Фармацевтическая композиция с покрытием, содержащая регорафениб | |
| ES2606627T8 (es) | Anticuerpos específicos anti-CD160 para el tratamiento de trastornos oculares basados en la neoangiogénesis | |
| EA201170356A1 (ru) | Полиморфные и аморфные формы лакозамида и аморфные композиции | |
| GEP20156339B (en) | New co-crystals of agomelatine, process for their preparation and pharmaceutical compositions containing them | |
| IL232334A0 (en) | Modulators of the G protein-coupled mas receptor and the treatment of related disorders | |
| BRPI0917440A2 (pt) | composições farmacêuticas oftálmicas para o tratamento de patologias neoangiogênicas do olho | |
| MX2014000142A (es) | Uso de anticuerpos agonistas anti-cd83 para tratar enfermedades autoinmunes. | |
| MX362271B (es) | Nueva forma cristalina de ciclosporina a, metodos de preparacion y metodos para su uso. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/06/2011, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO. |